Veterinary Medicines

Nobilis RT + IB multi + G + ND emulsja do wstrzykiwań dla kur

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RT + IB multi + G + ND emulsja do wstrzykiwań dla kur
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    1.00
    unknown
    /
    1.00
    unknown
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    1.00
    unknown
    /
    1.00
    unknown
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    1.00
    unknown
    /
    1.00
    unknown
  • Infectious bursal disease virus, strain D78, Inactivated
    1.00
    unknown
    /
    1.00
    unknown
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    1.00
    50% Protective Dose
Pharmaceutical form:
  • Emulsion for injection/infusion
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1131
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download